Bank of America’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.35B | Sell |
17,690,462
-1,367,865
| -7% | -$257M | 0.22% | 96 |
|
|
2026
Q1 | $3.76B | Buy |
19,058,327
+5,880,151
| +45% | +$1.13B | 0.27% | 77 |
|
|
2025
Q4 | $2.42B | Sell |
13,178,176
-3,138,394
| -19% | -$550M | 0.18% | 117 |
|
|
2025
Q3 | $2.5B | Buy |
16,316,570
+730,893
| +5% | +$111M | 0.17% | 121 |
|
|
2025
Q2 | $2.18B | Sell |
15,585,677
-330,831
| -2% | -$46.4M | 0.16% | 133 |
|
|
2025
Q1 | $2.34B | Buy |
15,916,508
+3,903,025
| +32% | +$565M | 0.19% | 116 |
|
|
2024
Q4 | $1.57B | Sell |
12,013,483
-921,913
| -7% | -$129M | 0.13% | 156 |
|
|
2024
Q3 | $2.02B | Buy |
12,935,396
+5,005,051
| +63% | +$808M | 0.16% | 131 |
|
|
2024
Q2 | $1.24B | Buy |
7,930,345
+1,367,683
| +21% | +$206M | 0.11% | 191 |
|
|
2024
Q1 | $889M | Buy |
6,562,662
+799,701
| +14% | +$106M | 0.08% | 250 |
|
|
2023
Q4 | $776M | Sell |
5,762,961
-357,615
| -6% | -$46.5M | 0.08% | 255 |
|
|
2023
Q3 | $829M | Buy |
6,120,576
+841,532
| +16% | +$115M | 0.09% | 223 |
|
|
2023
Q2 | $756M | Buy |
5,279,044
+189,184
| +4% | +$27.8M | 0.08% | 245 |
|
|
2023
Q1 | $707M | Buy |
5,089,860
+249,958
| +5% | +$33.6M | 0.07% | 261 |
|
|
2022
Q4 | $656M | Sell |
4,839,902
-978,555
| -17% | -$123M | 0.07% | 262 |
|
|
2022
Q3 | $638M | Buy |
5,818,457
+2,817
| +0% | +$357K | 0.08% | 255 |
|
|
2022
Q2 | $768M | Buy |
5,815,640
+230,694
| +4% | +$30.3M | 0.09% | 226 |
|
|
2022
Q1 | $741M | Buy |
5,584,946
+280,035
| +5% | +$33.6M | 0.07% | 259 |
|
|
2021
Q4 | $618M | Buy |
5,304,911
+92,205
| +2% | +$10.8M | 0.06% | 299 |
|
|
2021
Q3 | $626M | Buy |
5,212,706
+385,896
| +8% | +$44.9M | 0.06% | 291 |
|
|
2021
Q2 | $578M | Sell |
4,826,810
-3,602
| -0.1% | -$395K | 0.06% | 310 |
|
|
2021
Q1 | $480M | Buy |
4,830,412
+287,759
| +6% | +$28.9M | 0.05% | 325 |
|
|
2020
Q4 | $454M | Buy |
4,542,653
+275,294
| +6% | +$29.2M | 0.06% | 298 |
|
|
2020
Q3 | $468M | Buy |
4,267,359
+107,130
| +3% | +$11.9M | 0.06% | 266 |
|
|
2020
Q2 | $440M | Buy |
4,160,229
+123,188
| +3% | +$12.7M | 0.07% | 266 |
|
|
2020
Q1 | $361M | Sell |
4,037,041
-504,657
| -11% | -$47.5M | 0.06% | 266 |
|
|
2019
Q4 | $453M | Sell |
4,541,698
-558,730
| -11% | -$52.6M | 0.06% | 283 |
|
|
2019
Q3 | $455M | Sell |
5,100,428
-3,818,750
| -43% | -$331M | 0.07% | 282 |
|
|
2019
Q2 | $736M | Sell |
8,919,178
-648,230
| -7% | -$50.8M | 0.11% | 189 |
|
|
2019
Q1 | $774M | Sell |
9,567,408
-3,081,325
| -24% | -$243M | 0.12% | 179 |
|
|
2018
Q4 | $961M | Sell |
12,648,733
-1,060,799
| -8% | -$82.8M | 0.17% | 145 |
|
|
2018
Q3 | $1.08B | Sell |
13,709,532
-1,629,887
| -11% | -$123M | 0.17% | 137 |
|
|
2018
Q2 | $1.08B | Sell |
15,339,419
-4,801,178
| -24% | -$345M | 0.18% | 132 |
|
|
2018
Q1 | $1.41B | Sell |
20,140,597
-1,453,534
| -7% | -$101M | 0.24% | 102 |
|
|
2017
Q4 | $1.5B | Sell |
21,594,131
-1,622,732
| -7% | -$109M | 0.25% | 97 |
|
|
2017
Q3 | $1.57B | Buy |
23,216,863
+173,531
| +0.8% | +$11M | 0.25% | 100 |
|
|
2017
Q2 | $1.57B | Buy |
23,043,332
+170,844
| +0.7% | +$11.2M | 0.31% | 76 |
|
|
2017
Q1 | $1.42B | Buy |
22,872,488
+5,207,484
| +29% | +$303M | 0.28% | 85 |
|
|
2016
Q4 | $965M | Sell |
17,665,004
-1,693,233
| -9% | -$96.1M | 0.21% | 118 |
|
|
2016
Q3 | $1.27B | Buy |
19,358,237
+2,228,804
| +13% | +$146M | 0.28% | 83 |
|
|
2016
Q2 | $1.03B | Buy |
17,129,433
+3,687,594
| +27% | +$214M | 0.24% | 102 |
|
|
2016
Q1 | $757M | Buy |
13,441,839
+2,116,441
| +19% | +$127M | 0.18% | 131 |
|
|
2015
Q4 | $769M | Buy |
11,325,398
+577,962
| +5% | +$37.9M | 0.18% | 126 |
|
|
2015
Q3 | $684M | Buy |
10,747,436
+5,060,103
| +89% | +$333M | 0.17% | 134 |
|
|
2015
Q2 | $362M | Buy |
5,687,333
+374,745
| +7% | +$25.7M | 0.12% | 195 |
|
|
2015
Q1 | $364M | Buy |
5,312,588
+977,407
| +23% | +$67.9M | 0.12% | 194 |
|
|
2014
Q4 | $305M | Buy |
4,335,181
+3,729,784
| +616% | +$267M | 0.11% | 215 |
|
|
2014
Q3 | $43.3M | Sell |
605,397
-52,801
| -8% | -$3.86M | 0.01% | 918 |
|
|
2014
Q2 | $48.9M | Buy |
658,198
+217,953
| +50% | +$15.8M | 0.02% | 839 |
|
|
2014
Q1 | $28.6M | Sell |
440,245
-77,437
| -15% | -$5M | 0.01% | 1044 |
|
|
2013
Q4 | $30.7M | Buy |
517,682
+226,036
| +78% | +$12.3M | 0.01% | 1033 |
|
|
2013
Q3 | $15.1M | Sell |
291,646
-67,308
| -19% | -$3.38M | 0.01% | 1460 |
|
|
2013
Q2 | $17M | Buy |
+358,954
| New | +$18.3M | 0.01% | 1319 |
|
Other funds holding AZN
EP
IA
Bank of America's AZN Position: Q2 2026 in Review
Bank of America reduced its AstraZeneca (AZN) stake by 7.2% in Q2 2026, selling an estimated $257M and leaving 17,690,462 shares worth $3.35B. The position accounts for 0.22% of the portfolio, ranked #96.
Bank of America first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.76B in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Bank of America held 17,690,462 shares of AstraZeneca worth $3.35B as of Q2 2026.
- Bank of America sold 1,367,865 AstraZeneca shares in Q2 2026, an estimated $257M.
- AstraZeneca made up 0.22% of Bank of America's portfolio in Q2 2026, its #96 holding.
- Bank of America first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- Bank of America's AstraZeneca position peaked at $3.76B in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.